D-1312-2016 Class II Terminated

Recalled by Pharmakon Pharmaceuticals, Inc. — Noblesville, IN

FDA drug recall D-1312-2016 was initiated by Pharmakon Pharmaceuticals, Inc. on April 20, 2016 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is terminated (terminated January 11, 2018). Affected quantity: 675.

Recall Details

Product Type
Drugs
Report Date
July 20, 2016
Initiation Date
April 20, 2016
Termination Date
January 11, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
675

Product Description

Hydromorphone HCI 1 mg/mL in 0.9% Sodium Chloride, 50 mL lntravia bag IV USE ONLY, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060 , NDC 45183-0865-41

Reason for Recall

Lack of Assurance of Sterility

Distribution Pattern

Nationwide VA/DOD: CA, KY, MD, NC, OK, TX, VA

Code Information

All Sterile Compounded Products within Expiry